Literature DB >> 20444420

Resistance to high-fat diet-induced obesity and insulin resistance in mice with very long-chain acyl-CoA dehydrogenase deficiency.

Dongyan Zhang1, Jennifer Christianson, Zhen-Xiang Liu, Liqun Tian, Cheol Soo Choi, Susanne Neschen, Jianying Dong, Philip A Wood, Gerald I Shulman.   

Abstract

Mitochondrial fatty acid oxidation provides an important energy source for cellular metabolism, and decreased mitochondrial fatty acid oxidation has been implicated in the pathogenesis of type 2 diabetes. Paradoxically, mice with an inherited deficiency of the mitochondrial fatty acid oxidation enzyme, very long-chain acyl-CoA dehydrogenase (VLCAD), were protected from high-fat diet-induced obesity and liver and muscle insulin resistance. This was associated with reduced intracellular diacylglycerol content and decreased activity of liver protein kinase Cvarepsilon and muscle protein kinase Ctheta. The increased insulin sensitivity in the VLCAD(-/-) mice were protected from diet-induced obesity and insulin resistance due to chronic activation of AMPK and PPARalpha, resulting in increased fatty acid oxidation and decreased intramyocellular and hepatocellular diacylglycerol content.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20444420      PMCID: PMC3146169          DOI: 10.1016/j.cmet.2010.03.012

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  33 in total

1.  Gestational, pathologic and biochemical differences between very long-chain acyl-CoA dehydrogenase deficiency and long-chain acyl-CoA dehydrogenase deficiency in the mouse.

Authors:  K B Cox; D A Hamm; D S Millington; D Matern; J Vockley; P Rinaldo; C A Pinkert; W J Rhead; J R Lindsey; P A Wood
Journal:  Hum Mol Genet       Date:  2001-09-15       Impact factor: 6.150

2.  Molecular basis for the substrate specificity of protein kinase B; comparison with MAPKAP kinase-1 and p70 S6 kinase.

Authors:  D R Alessi; F B Caudwell; M Andjelkovic; B A Hemmings; P Cohen
Journal:  FEBS Lett       Date:  1996-12-16       Impact factor: 4.124

3.  Relative contribution of glycogen synthesis and glycolysis to insulin-mediated glucose uptake. A dose-response euglycemic clamp study in normal and diabetic rats.

Authors:  L Rossetti; A Giaccari
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

4.  Steatohepatitis, spontaneous peroxisome proliferation and liver tumors in mice lacking peroxisomal fatty acyl-CoA oxidase. Implications for peroxisome proliferator-activated receptor alpha natural ligand metabolism.

Authors:  C Y Fan; J Pan; N Usuda; A V Yeldandi; M S Rao; J K Reddy
Journal:  J Biol Chem       Date:  1998-06-19       Impact factor: 5.157

5.  Very-long-chain acyl-coenzyme a dehydrogenase deficiency in mice.

Authors:  Vernat J Exil; Richard L Roberts; Harold Sims; Jacquelin E McLaughlin; Robert A Malkin; Carla D Gardner; Gemin Ni; Jeffrey N Rottman; Arnold W Strauss
Journal:  Circ Res       Date:  2003-07-31       Impact factor: 17.367

6.  Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes.

Authors:  David E Kelley; Jing He; Elizabeth V Menshikova; Vladimir B Ritov
Journal:  Diabetes       Date:  2002-10       Impact factor: 9.461

7.  Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators.

Authors:  S S Lee; T Pineau; J Drago; E J Lee; J W Owens; D L Kroetz; P M Fernandez-Salguero; H Westphal; F J Gonzalez
Journal:  Mol Cell Biol       Date:  1995-06       Impact factor: 4.272

8.  Influence of dietary fat composition on development of insulin resistance in rats. Relationship to muscle triglyceride and omega-3 fatty acids in muscle phospholipid.

Authors:  L H Storlien; A B Jenkins; D J Chisholm; W S Pascoe; S Khouri; E W Kraegen
Journal:  Diabetes       Date:  1991-02       Impact factor: 9.461

9.  Cardiac hypertrophy in mice with long-chain acyl-CoA dehydrogenase or very long-chain acyl-CoA dehydrogenase deficiency.

Authors:  Keith B Cox; Jian Liu; Liqun Tian; Stephen Barnes; Qinglin Yang; Philip A Wood
Journal:  Lab Invest       Date:  2009-09-07       Impact factor: 5.662

10.  Covalent activation of heart AMP-activated protein kinase in response to physiological concentrations of long-chain fatty acids.

Authors:  Hilary Clark; David Carling; David Saggerson
Journal:  Eur J Biochem       Date:  2004-06
View more
  46 in total

1.  A mouse model of diet-induced obesity and insulin resistance.

Authors:  Chao-Yung Wang; James K Liao
Journal:  Methods Mol Biol       Date:  2012

2.  Emerging Pharmacological Targets for the Treatment of Nonalcoholic Fatty Liver Disease, Insulin Resistance, and Type 2 Diabetes.

Authors:  Leigh Goedeke; Rachel J Perry; Gerald I Shulman
Journal:  Annu Rev Pharmacol Toxicol       Date:  2019-01-06       Impact factor: 13.820

Review 3.  Metabolic pathways at the crossroads of diabetes and inborn errors.

Authors:  Eric S Goetzman; Zhenwei Gong; Manuel Schiff; Yan Wang; Radhika H Muzumdar
Journal:  J Inherit Metab Dis       Date:  2017-09-26       Impact factor: 4.982

4.  Intrahepatic diacylglycerol content is associated with hepatic insulin resistance in obese subjects.

Authors:  Faidon Magkos; Xiong Su; David Bradley; Elisa Fabbrini; Caterina Conte; J Christopher Eagon; J Esteban Varela; Elizabeth M Brunt; Bruce W Patterson; Samuel Klein
Journal:  Gastroenterology       Date:  2012-03-13       Impact factor: 22.682

5.  CrbpI modulates glucose homeostasis and pancreas 9-cis-retinoic acid concentrations.

Authors:  Maureen A Kane; Alexandra E Folias; Attilio Pingitore; Mariarita Perri; Charles R Krois; Joo Yeon Ryu; Erika Cione; Joseph L Napoli
Journal:  Mol Cell Biol       Date:  2011-06-13       Impact factor: 4.272

6.  Specific Inhibition of Acyl-CoA Oxidase-1 by an Acetylenic Acid Improves Hepatic Lipid and Reactive Oxygen Species (ROS) Metabolism in Rats Fed a High Fat Diet.

Authors:  Jia Zeng; Senwen Deng; Yiping Wang; Ping Li; Lian Tang; Yefeng Pang
Journal:  J Biol Chem       Date:  2017-01-11       Impact factor: 5.157

7.  Imeglimin lowers glucose primarily by amplifying glucose-stimulated insulin secretion in high-fat-fed rodents.

Authors:  Rachel J Perry; Rebecca L Cardone; Max C Petersen; Dongyan Zhang; Pascale Fouqueray; Sophie Hallakou-Bozec; Sébastien Bolze; Gerald I Shulman; Kitt Falk Petersen; Richard G Kibbey
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-07-12       Impact factor: 4.310

8.  Rilmenidine improves hepatic steatosis through p38-dependent pathway to higher the expression of farnesoid X receptor.

Authors:  Po-Sheng Yang; Hung-Tsung Wu; Hsien-Hui Chung; Chun-Ta Chen; Chin-Wen Chi; Ching-Hua Yeh; Juei-Tang Cheng
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-09-25       Impact factor: 3.000

9.  Loss of Hepatic Mitochondrial Long-Chain Fatty Acid Oxidation Confers Resistance to Diet-Induced Obesity and Glucose Intolerance.

Authors:  Jieun Lee; Joseph Choi; Ebru S Selen Alpergin; Liang Zhao; Thomas Hartung; Susanna Scafidi; Ryan C Riddle; Michael J Wolfgang
Journal:  Cell Rep       Date:  2017-07-18       Impact factor: 9.423

10.  High sugar and butter (HSB) diet induces obesity and metabolic syndrome with decrease in regulatory T cells in adipose tissue of mice.

Authors:  Tatiani Uceli Maioli; Juliana Lauar Gonçalves; Mariana Camila Gonçalves Miranda; Vinícius Dantas Martins; Laila Sampaio Horta; Thais Garcias Moreira; Ana Lucia Brunialti Godard; Andrezza Fernanda Santiago; Ana Maria Caetano Faria
Journal:  Inflamm Res       Date:  2015-12-09       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.